Description
In light of the COVID-19 outbreak, Health Canada is clarifying expectations for manufacturers, importers and market authorization holders (MAHs) regarding requirement to report adverse reactions (ARs) and medical device problems (MDPs) during a pandemic.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Notice for Industry: Mandatory Reporting Requirement during the COVID-19 Pandemic | HTML | Open resource | |
| Notice for Industry: Mandatory Reporting Requirement during the COVID-19 Pandemic | HTML | Open resource |